TITLE

Breast cancer death rates decline for white women

AUTHOR(S)
Smigel, Kara
PUB. DATE
February 1995
SOURCE
JNCI: Journal of the National Cancer Institute;2/1/95, Vol. 87 Issue 3, p173
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the decrease in breast cancer mortality among white women in the United States as of 1992. Increase in breast cancer mortality among African-American women; Recommended treatment options; Increase in the use of mammography; Importance of continuing the fight against breast cancer.
ACCESSION #
9502143901

 

Related Articles

  • Geographic Variations in Breast Cancer Mortality: Do Higher Rates Imply Elevated Incidence or Poorer Survival? Goodwin, James S.; Freeman, Jean L.; Freeman, Daniel; Nattinger, Ann B. // American Journal of Public Health;Mar98, Vol. 88 Issue 3, p458 

    Objectives. Mortality rates from breast cancer are approximately 25% higher for women in the northeastern United States than for women in the South or West. This study examined the hypothesis that the elevation is due to decreased survival rather than increased incidence. Methods. Data on breast...

  • Birth cohort and calendar period trends in breast cancer mortality in the United States and Canada. Tarone, Robert E.; Chu, Kenneth C. // JNCI: Journal of the National Cancer Institute;02/05/97, Vol. 89 Issue 3, p251 

    Compares breast cancer mortality rates from 1969 through 1992 for white women and black women in the United States and Canada to identify racial, regional and temporal differences. Evaluation of trends in view of breast cancer risk factors and relevant medical interventions; Marked moderation of...

  • Pregnancy no risk for breast cancer patients.  // Australian Nursing Journal;Sep97, Vol. 5 Issue 3, p17 

    Cites a study on the risk of death among pregnant women with breast cancer. Comparison on the death rate of women with breast cancer who became pregnant and to those who did not.

  • Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients. Gamel, J.W.; Vogel, R.L. // Statistical Methods in Medical Research;Oct2001, Vol. 10 Issue 5, p339 

    Cancer-related mortality can be measured by two dissimilar methods: cause-specific survival (based on mortality attributed to a specific cause), and relative survival (based on mortality relative to a matched cohort). We used both methods to determine actuarial survival in a population of...

  • Fraction of normal remaining life span: A new method for expressing survival in cancer. Vaidya, Jayant S. // BMJ: British Medical Journal (International Edition);06/07/97, Vol. 314 Issue 7095, p1682 

    Discusses a method for calculating a cancer patient's survival curve. Conventional method of using time between diagnosis and last follow up or death to denote survival time; Illustration of new concept using database of breast cancer patients in Bombay, India; Comparison between conventional...

  • American Cancer Society: Racial disparities in breast cancer survival persist.  // Hem/Onc Today;1/25/2014, Vol. 15 Issue 2, p3 

    The article discusses a study led by epidemiologist Carol DeSantis, published in "CA: A Cancer Journal for Clinicians," on survival differences based on race and ethnicity among U.S. breast cancer patients, with black women showing the poorest survival rate.

  • Is Race Really a Negative Prognostic Factor for Cancer? Brawley, Otis W. // JNCI: Journal of the National Cancer Institute;7/15/2009, Vol. 101 Issue 14, p970 

    An introduction to the journal is presented in which the editor discusses an article on racial disparities in cancer survival by K. S. Albain and colleagues, black-white racial disparity in breast cancer mortality by I. Menashe and colleagues.

  • Screen detection associated with reduction in 10-year breast cancer-specific mortality.  // Hem/Onc Today;3/25/2011, Vol. 12 Issue 6, p32 

    The article reports that female invasive breast cancer patients with mammographically screen-detected tumors had superior disease-specific and all-cause mortality compared with women suffering from nonscreening-related carcinomas, which is based on a study conducted by S. Mook and colleagues.

  • Untitled. O'Callaghan, Tiffany // Time;4/26/2010, Vol. 175 Issue 16, p35 

    The article discusses epidemiological findings on the mortality of female breast cancer patients as correlated with their use of beta-blocker drugs for hypertension.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics